MeCure Industries PLC, a leading pharmaceutical manufacturer in Nigeria has successfully redeemed N3 billion Senior Secured Bond (Series 1) under its N20 billion Debt Issuance Programme.
The bond, originally issued on 14th May 2021, marked the company’s debut transaction in the Nigerian
capital market.
The full repayment underscores MeCure’s strong financial discipline, robust cash flow
management, and commitment to meeting its obligations to investors.
Speaking on the milestone, the Chief Financial Officer of MeCure Industries PLC commented:
“The successful redemption of our Series 1 bond is a significant achievement for MeCure. It reflects not
only our financial resilience but also the confidence that the capital markets placed in us during our
debut issuance. We are proud to have honored this obligation in full and on schedule.”
He further added:
“The company delivered a solid performance in 2025, driven by operational efficiency, expanded
market reach, and continued investment in manufacturing capabilities. As we look ahead, we are
optimistic about 2026, with a strong pipeline of opportunities that will support sustainable growth and
long-term value creation.”
READ ALSO:Amid Middle East War, Iran Set To Participate In 2026 World Cup, FIFA Boss Confirms
Since its issuance, the bond has played a key role in supporting MeCure’s strategic initiatives, including
capacity expansion, product development, and strengthening its distribution network across Nigeria
and export markets.
This milestone reinforces MeCure’s position as a credible and disciplined issuer in the Nigerian capital
market, setting a strong foundation for future engagements with investors as the company continues to
pursue its growth ambitions.
